← SynDRA
EPITIOSTANOL
SynDRA canonical compound SYN0031925 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | AR |
|---|
| Mechanism of action | Androgen receptor agonist |
|---|
| Indication | breast cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- epithiostanol
- thiodrol
- 10275-S
- NSC-194684
- Epitiostanolum
- Epithioandrostanol
- NSC 194684
- YE7586973L
- DTXCID0025367
- NSC194684
- RefChem:921055
- 2-alpha,3-alpha-Epithio-5-alpha-androstan-17-beta-ol
- Thiodrol
- 2,3-Epithioandrostan-17-ol
- Epitiostanol (1mg/ml in Acetonitrile)
- Epitiostanol [INN:JAN]
- Epitiostanolum [INN-Latin]
- UNII-YE7586973L
- NCGC00016609-01
- CAS-2363-58-8
- Epitiostanol (JAN/INN)
- EPITIOSTANOL [MI]
- EPITIOSTANOL [INN]
- EPITIOSTANOL [JAN]
- SCHEMBL8995
- 2.alpha.,3.alpha.-Epithio-5.alpha.-androstan-17.beta.-ol
- 2alpha,3alpha-Epithio-5alpha-androstan-17beta-ol
- EPITIOSTANOL [MART.]
- 2alpha,3alpha-Epithio-5alpha-androstan-17beta-o1
- EPITIOSTANOL [WHO-DD]
- CHEBI:31546
- Tox21_110520
- CCG-221006
- D01265
- 2alpha,3alpha-epithio-5alpha-androstane-17beta-ol
- 5alpha-Androstan-17beta-ol, 2alpha,3alpha-epithio-
- 2alpha,3alpha,5alpha-2,3-Epithioandrostan-17beta-ol
- BRD-K02314383-001-01-3
Look up EPITIOSTANOL in the interactive SynDRA portal →